Globus Medical beats, raises EPS guidance


Globus Medical's (GMED) Q3 numbers come in slightly ahead of the Street's expectations.

U.S. sales growth for the period was 12.6%, while international growth was 19.1%.

Net income rises 23% Y/Y to $20.3M.

FY13 outlook: $0.83-0.85/share (versus previous guidance of $0.81/share) on revenue of ~$432M. Consensus is $0.83/share on sales of $432.3M. (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs